Prostate cancer is the second-most-common cancer in men (after skin cancer) and the second-most-common cause of cancer-related death in men (after lung cancer). Latest data from the American Cancer Society: One in nine men will be diagnosed with prostate cancer in their lifetime, and one in 41 will die from
Tag: prostate cancer treatment
New Treatment Option for Prostate Cancer
UCLA researchers Leonard Marks, MD, and Shyam Natarajan, PhD will lead a $3.1 million research project grant awarded by the National Institutes of Health to advance the adoption of a promising new technology to treat men with prostate cancer. By helping to increase the widespread
Prostate cancer is the second-most-common cancer in men (after skin cancer) and the second-most-common cause of cancer-related death in men (after lung cancer). One in seven men will be diagnosed with prostate cancer in their lifetime.
To keep things in perspective, however, it is also one of the most survivable cancers:
The glandular cells of the prostate play an important role in reproduction, producing the fluids that help make up semen. These tiny cells also serve as the birthplace for nearly all prostate cancers. Genes in these cells slowly mutate, leading to the formation of abnormal cells. The cells proliferate and
Tai Chi Reduces Falls
A new study review indicates that the ancient Chinese martial art tai chi may help reduce the risk of falls among older adults. Researchers writing in the Journal of the American Geriatrics Society, July 24, looked at 10 randomized controlled trials whose participants, age 56 to 98,
New Treatment for Advanced Prostate Cancer.
A three-in-one blood test could aid advanced prostate cancer treatment through use of the PARP inhibitor olaparib (Lynparza), which targets mutations in the BRCA genes. PARP helps repair DNA when it becomes damaged. In cancer treatment, blocking PARP may prevent cancer cells from repairing their
After skin cancer, prostate cancer is the most common cancer in men, according to the American Cancer Society (ACS)—and six cases in 10 occur in men age 65 and older.
For some men, prostate cancer can be an aggressive disease, but for most, the disease is slow growing—in fact, men with
Older men who have early-stage prostate cancer, as well as other serious health problems, may be not be good candidates for aggressive cancer therapies such as surgery or radiation. A UCLA study found that early-stage prostate cancer patients aged 66 and older, who had other health concerns, such as diabetes
Prostate cancer stages describe how far a cancer of the prostate has spread. Doctors define stages in determining treatment for prostate cancer and in predicting the chances of recovery.
Prostate cancer stages are determined by evaluating the prostate tissue and determining its Gleason score (a microscopic assessment of the cells’ architecture
Newsbriefs: Blood Pressure & Dementia Risk; Intense Anger & Heart Attack Risk; Prostate Cancer & Dementia
Sudden Drops in Blood Pressure May Signal Greater Dementia Risk
Orthostatic hypotension—a sudden drop in blood pressure that occurs when rising to a standing position—may be tied to a greater risk for dementia, according to a large Dutch study published online Oct. 11, 2016 in the journal PLoS Medicine. The condition,